SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is drawing significant investor interest as the community highlights its unique Alpha DaRT technology and a robust pipeline of five concurrent U.S. clinical trials. Investors are actively discussing the company's strong cash position, recent marketing approval in Japan, and high-stakes upcoming trial data readouts as key catalysts that could drive the stock toward double-digit valuations.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing intense volatility and downward pressure as market participants weigh a controversial short report regarding competition from Anthropic against the stock's role as a mission-critical AI platform for government and enterprise clients. While many investors dismiss the negative sentiment as market manipulation aimed at shaking out retail holders, the community remains deeply divided, with some actively debating the long-term impact of AI market share shifts versus the company's established dominance in secure, enterprise-grade data integration.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space Inc. is trending as retail investors anticipate a potential valuation boost from the widely discussed SpaceX IPO, which many believe will force institutional capital into the broader, smaller-cap space sector to meet diversification requirements. The community is actively debating the company's long-term viability, with bulls focusing on speculative partnerships like the recent Blackstar Orbital collaboration and potential hypersonic testing contracts, while bears raise concerns about the lack of current revenue and the stock's recent price volatility.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant selling pressure and heightened volatility as investors weigh concerns over declining vehicle deliveries and analyst downgrades against persistent rumors of a potential SpaceX IPO. The community is sharply divided, with many debating whether the stock's valuation is disconnected from its fundamental business performance or if current price action represents a temporary dip before a potential rebound.

MATH is a one stop crypto solution platform which contains MathWallet, MATH VPOS Pool, MathDEX, MATH dApp Store, MATH Staking, MATH Pay, MATH Chain, etc.

MATH

MATH is trending as community members weigh the potential for a low-market-cap breakout against ongoing frustrations regarding perceived leadership stagnation and historical price volatility. Traders are actively debating whether current support levels signal an impending recovery or if the token will continue its pattern of brief, speculative rallies followed by extended downtrends.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is currently trending as investors closely monitor recent quarterly sales data and the company's defensive strength amid broader market volatility. The community remains actively focused on Costco's retail performance, potential membership fee strategies, and its unique ability to maintain premium valuation despite fluctuating macroeconomic conditions.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is currently drawing significant community attention as investors pivot toward the upcoming BlueBird 7 satellite launch and closely monitor potential collaboration signals from Meta. While the stock experiences high volatility driven by broader geopolitical tensions and market-wide shifts, bulls remain focused on the company's long-term infrastructure mission and its potential role in the evolving space economy.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospace is currently trending due to strong market optimism surrounding its robust engine production backlog and major military contract wins, which have solidified its status as a key defense and industrial player. Investors are actively discussing the company's long-term growth potential in aerospace, while some sentiment is also driven by recent legal settlement claims involving historical financial disclosures.

Ciena Corp. is a network technology company, which engages in the provision of hardware, software, and services to network operators, as well as enabling enhanced network capacity, service delivery, and automation. It operates through the following segments: Networking Platforms, Platform Software and Services, Blue Planet Automation Software and Services, and Global Services. The Networking Platforms segment consists of converged packet optical and packet networking portfolios. The Platform Software and Services segment provides analytics, data, and planning tools to assist customers in managing its networking platforms products. The Blue Planet Automation Software and Services segment enables customers to implement large-scale software and IT-led OSS transformations by transforming legacy networks into service ready networks. The Global Services segment offers a broad suite of value-added services. The company was founded by Patrick H. Nettles and Kevin Brian Kimberlin in 1992 and is headquartered in Hanover, MD.

CIENA Corp.

Ciena is experiencing significant market interest driven by robust data center demand and AI-focused infrastructure growth that consistently outperforms analyst expectations. The community is actively debating the stock's parabolic trajectory and aggressive valuation, with many traders closely monitoring for potential volatility as the company continues to secure new high-capacity networking projects.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is gaining significant momentum as investors cheer the successful Alpha Flight 7 mission, which validated key rocket upgrades and delivered a payload for Lockheed Martin. The community is buzzing about the stock's role in the broader space economy, with many traders closely watching the upcoming earnings release and the potential ripple effects of a highly anticipated SpaceX IPO.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CYDY 
Question if phase2 hiv trial was withdrawal due to Cro data management issue in 2022 by CYDY. Can Gates foundation use those data to move the trial further or they have to start HiV trial from beginning ??

Timothy OConnor

mitchmiller

StockTwits for iOS

CytoDyn Inc

 
Question if phase2 hiv trial was withdrawal due to Cro data management issue in 2022 by CYDY. Can Gates foundation use those data to move the trial further or they have to start HiV trial from beginning ??

Greenwich LifeSciences Inc

Tellor

Internet Computer

Hiren

@Hbhatwala You might also be interested in knowing that a Cytodyn press release in December 2024 said &quot;In addition, CytoDyn is preparing a draft manuscript summarizing the integrated safety data from the almost 1,600 patients who have now been treated with leronlimab.&quot; 
 
I mention it because the majority of those patients I believe were in the various HIV trials, and some of those patients received the drug for 7 years.  
 
IMO this data will be used to support any upcoming trials. Regarding the various HIV lines of research, I think that the LATCH (stem cell) study will start first and a clinical trial with the triple combo therapy will be second. I don&#39;t think they will start in phase 1.

LadyDuckSnot

Thomas Migliara

LIVIMMUNE Bound

vivamiga

Rod Schilz

StockTwits Web

 You might also be interested in knowing that a Cytodyn press release in December 2024 said "In addition, CytoDyn is preparing a draft manuscript summarizing the integrated safety data from the almost 1,600 patients who have now been treated with leronlimab." 
 
I mention it because the majority of those patients I believe were in the various HIV trials, and some of those patients received the drug for 7 years.  
 
IMO this data will be used to support any upcoming trials. Regarding the various HIV lines of research, I think that the LATCH (stem cell) study will start first and a clinical trial with the triple combo therapy will be second. I don't think they will start in phase 1.